Researchers believe new findings will provide a new pre-clinical model to understand the early events in mucosal HIV infection and help to evaluate candidate HIV vaccines.
MHRP initiated a large, long-term cohort study at multiple African sites that will evaluate HIV prevention care and treatment services it supports through local facilities.
A novel HIV vaccine candidate developed by MHRP scientists in collaboration with Advanced BioScience laboratories will be produced for potential use in clinical studies.
Two thousand people, military and civilian, gathered at an open house in Tanzania to learn about HIV/AIDS prevention and treatment services offered in their area.
